
- /
- Supported exchanges
- / US
- / ZURA.NASDAQ
Zura Bio Limited Class A Ordinary Shares (ZURA NASDAQ) stock market data APIs
Zura Bio Limited Class A Ordinary Shares Financial Data Overview
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development. It is also developing Torudokimab (ZB-880), a monoclonal antibody that neutralizes IL-33 to prevent ST2-dependent and ST2-independent inflammation, which has completed Phase 1/2 clinical studies; and Crebankitug (ZB-168), a monoclonal antibody that binds and neutralizes the IL-7 receptor alpha chain that impact on diseases driven by IL-7 and thymic stromal lymphopoietin immune pathways, which has completed Phase 1/1b clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Zura Bio Limited Class A Ordinary Shares (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Zura Bio Limited Class A Ordinary Shares data using free add-ons & libraries
Get Zura Bio Limited Class A Ordinary Shares Fundamental Data
Zura Bio Limited Class A Ordinary Shares Fundamental data includes:
- Net Revenue:
- EBITDA: -72 339 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: -0.3
Get Zura Bio Limited Class A Ordinary Shares End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Zura Bio Limited Class A Ordinary Shares News

Spotlight On 3 Promising Penny Stocks With Over $60M Market Cap
As the U.S. market navigates a period of volatility marked by tech stock declines and fluctuating indices, investors are keenly watching for opportunities that might offer stability amidst uncertainty...


Oppenheimer lowers Zura Bio stock price target to $16 on clinical updates
Investing.com - Oppenheimer lowered its price target on Zura Bio Ltd. (NASDAQ:ZURA) to $16.00 from $17.00 on Thursday, while maintaining an Outperform rating on the stock. The new target remains signi...

Zura Bio GAAP EPS of -$0.17
* Zura Bio press release [https://seekingalpha.com/pr/20201018-zura-bio-reports-second-quarter-2025-financial-results-and-recent-corporate-updates] (NASDAQ:ZURA [https://seekingalpha.com/symbol/ZURA...

3 Penny Stocks With Market Caps Over $70M Worth Watching
Over the last 7 days, the market has remained flat, while in the past 12 months it has risen by 14%, with earnings expected to grow by 15% per annum over the next few years. For investors willing to e...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.